Form 4 for CVSA Covista Inc.
Accepted 2026-05-12 16:53:11 ET · period of report 2026-05-08 · accession 0000730464-26-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-12 16:53 | 2026-05-08 | CVSA | Cox Karen Sue | Pres, Chamberlain Univ | S - Sale | $124.50 | -2,000 | 31.6K | -6% | -$249.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-08 | S | D | 2,000 | $124.50 | 31,596 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. (F2) Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. (F3) No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. (F4) This transaction was executed in multiple trades at prices ranging from $124.00 to $125.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |